PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PRCT vs. AGNC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


PRCTAGNC
YTD Return127.99%9.16%
1Y Return197.66%30.17%
3Y Return (Ann)32.34%-3.58%
Sharpe Ratio3.301.50
Sortino Ratio4.822.09
Omega Ratio1.551.27
Calmar Ratio5.690.80
Martin Ratio28.198.33
Ulcer Index7.39%3.70%
Daily Std Dev63.07%20.55%
Max Drawdown-63.51%-54.56%
Current Drawdown-3.55%-20.22%

Fundamentals


PRCTAGNC
Market Cap$5.17B$8.39B
EPS-$1.95$1.49
Total Revenue (TTM)$199.84M$2.51B
Gross Profit (TTM)$112.10M$2.88B
EBITDA (TTM)-$98.77M$4.87B

Correlation

-0.50.00.51.00.3

The correlation between PRCT and AGNC is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

PRCT vs. AGNC - Performance Comparison

In the year-to-date period, PRCT achieves a 127.99% return, which is significantly higher than AGNC's 9.16% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-10.00%0.00%10.00%20.00%30.00%40.00%50.00%JuneJulyAugustSeptemberOctoberNovember
46.31%
4.35%
PRCT
AGNC

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PRCT vs. AGNC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for PROCEPT BioRobotics Corporation (PRCT) and AGNC Investment Corp. (AGNC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PRCT
Sharpe ratio
The chart of Sharpe ratio for PRCT, currently valued at 3.30, compared to the broader market-4.00-2.000.002.004.003.30
Sortino ratio
The chart of Sortino ratio for PRCT, currently valued at 4.82, compared to the broader market-4.00-2.000.002.004.006.004.82
Omega ratio
The chart of Omega ratio for PRCT, currently valued at 1.55, compared to the broader market0.501.001.502.001.55
Calmar ratio
The chart of Calmar ratio for PRCT, currently valued at 5.69, compared to the broader market0.002.004.006.005.69
Martin ratio
The chart of Martin ratio for PRCT, currently valued at 28.19, compared to the broader market0.0010.0020.0030.0028.19
AGNC
Sharpe ratio
The chart of Sharpe ratio for AGNC, currently valued at 1.50, compared to the broader market-4.00-2.000.002.004.001.50
Sortino ratio
The chart of Sortino ratio for AGNC, currently valued at 2.09, compared to the broader market-4.00-2.000.002.004.006.002.09
Omega ratio
The chart of Omega ratio for AGNC, currently valued at 1.27, compared to the broader market0.501.001.502.001.27
Calmar ratio
The chart of Calmar ratio for AGNC, currently valued at 0.93, compared to the broader market0.002.004.006.000.93
Martin ratio
The chart of Martin ratio for AGNC, currently valued at 8.33, compared to the broader market0.0010.0020.0030.008.33

PRCT vs. AGNC - Sharpe Ratio Comparison

The current PRCT Sharpe Ratio is 3.30, which is higher than the AGNC Sharpe Ratio of 1.50. The chart below compares the historical Sharpe Ratios of PRCT and AGNC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00JuneJulyAugustSeptemberOctoberNovember
3.30
1.50
PRCT
AGNC

Dividends

PRCT vs. AGNC - Dividend Comparison

PRCT has not paid dividends to shareholders, while AGNC's dividend yield for the trailing twelve months is around 15.21%.


TTM20232022202120202019201820172016201520142013
PRCT
PROCEPT BioRobotics Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
AGNC
AGNC Investment Corp.
15.21%14.68%13.91%9.57%10.00%11.31%12.31%10.70%12.69%14.30%11.96%19.44%

Drawdowns

PRCT vs. AGNC - Drawdown Comparison

The maximum PRCT drawdown since its inception was -63.51%, which is greater than AGNC's maximum drawdown of -54.56%. Use the drawdown chart below to compare losses from any high point for PRCT and AGNC. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-3.55%
-12.72%
PRCT
AGNC

Volatility

PRCT vs. AGNC - Volatility Comparison

PROCEPT BioRobotics Corporation (PRCT) has a higher volatility of 30.92% compared to AGNC Investment Corp. (AGNC) at 7.00%. This indicates that PRCT's price experiences larger fluctuations and is considered to be riskier than AGNC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%JuneJulyAugustSeptemberOctoberNovember
30.92%
7.00%
PRCT
AGNC

Financials

PRCT vs. AGNC - Financials Comparison

This section allows you to compare key financial metrics between PROCEPT BioRobotics Corporation and AGNC Investment Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items